MicroRNA-155 is essential for the optimal proliferation and survival of plasmablast B cells | Life Science Alliance

Advertisement

Research Article

Published 16 May 2019. DOI: 10.26508/lsa.201800244

Article Information

vol. 2 no. 3 e201800244

DOI

https://doi.org/10.26508/lsa.201800244

PubMed

Published By

Life Science Alliance

Online ISSN

History

Received November 14, 2018
Revision received April 29, 2019
Accepted April 30, 2019
Published online May 16, 2019.

Copyright & Usage

© 2019 Arbore et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).

Author Information

Giuseppina Arbore1,*,
Tom Henley1,*,
Laura Biggins3,
Simon Andrews3,
Elena Vigorito1,
Martin Turner1 and
Rebecca Leyland1,2 ⇑

¹Lymphocyte Signalling and Development, Babraham Institute, Cambridge, UK
²Biomolecular Sciences Research Centre, Sheffield Hallam University, Sheffield, UK
³Bioinformatics, Babraham Institute, Cambridge, UK

Correspondence: R.Leyland{at}shu.ac.uk

↵* Giuseppina Arbore and Tom Henley contributed equally to this work.

Giuseppina Arbore’s present address is Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.
Tom Henley’s present address is Empyrean Therapeutics Ltd, Building 250, Babraham Research Campus, Cambridge, UK.
Elena Vigorito’s present address is MRC Biostatistics Unit, School of Clinical Medicine, Cambridge Institute of Public Health, Cambridge Biomedical Campus, Cambridge, UK.

Funding

Biotechnology and Biological Sciences Research Council
BB/J00152X/1
Medical Research Council
BBS/E/B/000C0407

Advertisement

Subjects

Immunology